Micro Learning: Black Cisgender and Trans Women, HIV Treatment, & PrEP
Resource updated 05/10/2023
Resource updated 05/10/2023
Resource from the RWHAP Best Practices Compilation updated on 11/30/2023
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource from the RWHAP Best Practices Compilation updated on 11/17/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 01/08/2024
Resource updated 03/11/2024
Resource updated 06/05/2024
Blog updated 02/28/2023
Resource from the RWHAP Best Practices Compilation updated on 11/30/2023
Resource updated 03/04/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
This poster will provide information about approaches of the Black Women First Initiative in adressing HIV epidemic through the COVID-19 pandemic. Various strategies were developed and adapted by the 12 RWHAP SPNS demonstration sites by changing their existing systems for a more culturally responsive care for Black women with HIV.
Resource (Conference Presentation) updated 04/23/2024
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023